CLINICAL TRIALS PROFILE FOR CYANOKIT
✉ Email this page to a colleague
All Clinical Trials for CYANOKIT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03783091 ↗ | A Trial of Vitamin B12 in Septic Shock | Recruiting | Medical College of Wisconsin | Phase 2 | 2019-08-05 | This study will randomize 30 septic shock patients to receive either a single 5 gram dose of IV vitamin B12 (Cyanokit® Meridian Medical Technologies, Columbia, MD) versus placebo in addition to standard of care to reduce vasopressor dose at 3 hours. |
NCT04054999 ↗ | Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients | Recruiting | Mayo Clinic | Phase 4 | 2021-12-30 | This study will evaluate if Hydroxocobalamin may be a new and possibly superior treatment for refractory vasoplegic syndrome during liver transplant surgery. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CYANOKIT
Condition Name
Clinical Trial Locations for CYANOKIT
Trials by Country
Clinical Trial Progress for CYANOKIT
Clinical Trial Phase
Clinical Trial Sponsors for CYANOKIT
Sponsor Name